CSL News: CDC Advisory Committee Includes FLUAD® QUADRIVALENT as a Preferentially Recommended Influenza Vac - 23rd Jun 2022, 7:30am

[annb0t]

ACIP recommends adults 65 years of age and older receive an enhanced flu vaccine, such as FLUAD® QUADRIVALENT (Influenza Vaccine, Adjuvanted), to help protect against four strains of seasonal influenza annually The committee reviewed randomized studies and real-world data spanning multiple seasons and numerous flu-related outcomes in support of FLUAD QUADRIVALENT to inform their recommendation

SUMMIT, N.J., June 22, 2022 /PRNewswire/ -- Seqirus, a global leader in influenza prevention and...

>>> Read more: CDC Advisory Committee Includes FLUAD® QUADRIVALENT as a Preferentially Recommended Influenza Vaccine for Adults 65 and Older